Evidence map›Paper›PMID 34944055›Full record

Observational studyCells2021

Functional Ex Vivo Testing of Alveolar Monocytes in Patients with Pneumonia-Related ARDS.

Inès Bendib, Asma Beldi-Ferchiou, Frédéric Schlemmer, Bernard Maitre, Mathieu Surenaud, Sophie Hüe, Guillaume Carteaux, Keyvan Razazi, Jean-Daniel Lelièvre, Yves Lévy and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Observational
  5. Observational
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Inès BendibService de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, CEDEX, Créteil, 94010 Paris, France.
Asma Beldi-FerchiouINSERM, IMRB, Université Paris Est Créteil, CEDEX, Créteil, 94010 Paris, France.
Frédéric SchlemmerINSERM, IMRB, Université Paris Est Créteil, CEDEX, Créteil, 94010 Paris, France.
Bernard MaitreINSERM, IMRB, Université Paris Est Créteil, CEDEX, Créteil, 94010 Paris, France.
Mathieu SurenaudINSERM, IMRB, Université Paris Est Créteil, CEDEX, Créteil, 94010 Paris, France.
Sophie HüeINSERM, IMRB, Université Paris Est Créteil, CEDEX, Créteil, 94010 Paris, France.
Guillaume CarteauxService de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, CEDEX, Créteil, 94010 Paris, France.
Keyvan RazaziService de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, CEDEX, Créteil, 94010 Paris, France.
Jean-Daniel LelièvreINSERM, IMRB, Université Paris Est Créteil, CEDEX, Créteil, 94010 Paris, France.ORCID 0000-0002-8182-3628
Yves LévyINSERM, IMRB, Université Paris Est Créteil, CEDEX, Créteil, 94010 Paris, France.
Armand Mekontso DessapService de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, CEDEX, Créteil, 94010 Paris, France.ORCID 0000-0001-5961-5577
Véronique GodotINSERM, IMRB, Université Paris Est Créteil, CEDEX, Créteil, 94010 Paris, France.ORCID 0000-0003-3557-308X
Nicolas de ProstService de Médecine Intensive Réanimation, Hôpitaux Universitaires Henri Mondor, Assistance Publique-Hôpitaux de Paris, CEDEX, Créteil, 94010 Paris, France.ORCID 0000-0002-4833-4320
Inserm · FR

Funding

French Intensive Care Society 2016 Master 2 grantFrench Intensive Care Society Bourse Recherche Clinique 2013
6 · The paper itself

Abstract

Biomarkers of disease severity might help with individualizing the management of patients with acute respiratory distress syndrome (ARDS). During sepsis, a sustained decreased expression of the antigen-presenting molecule human leucocyte antigen-DR (HLA-DR) on circulating monocytes is used as a surrogate marker of immune failure. This study aimed at assessing whether HLA-DR expression on alveolar monocytes in the setting of a severe lung infection is associated with their functional alterations. BAL fluid and blood from immunocompetent patients with pneumonia-related ARDS admitted between 2016 and 2018 were isolated in a prospective monocentric study. Alveolar and blood monocytes were immunophenotyped using flow cytometry. Functional tests were performed on alveolar and blood monocytes after in vitro lipopolysaccharide (LPS) stimulation. Phagocytosis activity and intracellular tumor necrosis factor (TNF) production were quantified using fluorochrome-conjugated-specific antibodies. Ten ARDS and seven non-ARDS control patients were included. Patients with pneumonia-related ARDS exhibited significantly lower HLA-DR expression both on circulating (

Indexed as

AdultAgedB7-H1 AntigenBronchoalveolar Lavage FluidEscherichia coliFemaleHLA-DR AntigensHumansMaleMiddle AgedMonocytesPhagocytosisPneumoniaPulmonary AlveoliRespiratory Distress SyndromeTumor Necrosis Factor-alphaB7-H1 AntigenCD274 protein, humanHLA-DR AntigensTumor Necrosis Factor-alphaacute respiratory distress syndromeHLA-DRphagocytosispneumoniaTNF

Identifiers

PMID34944055
PMCPMC8700060
OpenAlexW4200020665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.